半岛bd体育手机客户端 说明
一般描述
A cell-permeable pyrazolopyrimidine compound that is shown to inhibit Src family tyrosine kinases Lck, Fyn, Hck, and Src (IC50= 5, 6, 20, and 170 nM, respectively), as well as non-Src family kinases such as CSK, RIP2, and CK1δ (IC50= 640 nM, 26 nM, 170 nM, respectively), inin vitrokinase assays. At 1 ?M,in vitrokinase activity is reduced by more than 57% for p38α, p38β, CK1δ, CSK, RIP2, and GAK, while exhibiting much lower activity against more than 60 other kinases. Kinetic studies employing Src and [poly Glu-Tyr 4:1] indicate that the inhibition is mixed competitive with respect to the substrate and non-competitive with respect to ATP. PP1 also demonstrates anti-growth properties in several B lymphoma cultures of human and murine origins (IC50= 2.5 to 8.0 ?M) and pediatric brain tumor cells (IC50= 1.1 to 9.7 ?M). 1 mg of Src Inhibitor, PP1 (Cat. No. 567809) is also available.
A cell-permeable pyrazolopyrimidine compound that is shown to inhibit Src family tyrosine kinases Lck, Fyn, Hck, and Src (IC50= 5, 6, 20, and 170 nM, respectively), as well as non-Src family kinases such as CSK, RIP2, and CK1δ (IC50= 640 nM, 26 nM, 170 nM, respectively), inin vitrokinase assays. At 1 ?M,in vitrokinase activity is reduced by more than 57% for p38α, p38β, CK1δ, CSK, RIP2, and GAK, while exhibiting much lower activity against more than 60 other kinases. Kinetic studies employing Src and [poly Glu-Tyr 4:1] indicate that the inhibition is mixed competitive with respect to the substrate and non-competitive with respect to ATP. PP1 also demonstrates anti-growth properties in several B lymphoma cultures of human and murine origins (IC50= 2.5 to 8.0 ?M) and pediatric brain tumor cells (IC50= 1.1 to 9.7 ?M).
包装
5 mg in Glass bottle
Packaged under inert gas
警告
Toxicity: Irritant (B)
外形
A 50 mM (5 mg/355 ?l) solution of Src Inhibitor, PP1 (Cat. No. 567809) in DMSO.
重悬
Following initial thaw, aliquot and freeze (-20°C).
其他说明
Ke, J., et.al. 2009.Mol. Cancer8,132.
Sikkema, A.H., et al. 2009.Cancer Res.69,5987.
Bain, J., et al. 2007.Biochem. J.408,297.
Bain, J., et al. 2003.Biochem. J.371,199.
Karni, R., et al. 2003.FEBS Lett.537,47.
Hanke, J.H., et al. 1996.J. Biol. Chem.271,695.
法律信息
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
基本信息
| 经验(实验)分子式 | C16H19N5 |
| 分子量 | 281.36 |
半岛bd体育手机客户端 性质
| 质量水平 | 100 |
| 测定 | ≥90% (HPLC) |
| 形式 | liquid |
| manufacturer/tradename | Calbiochem? |
| 储存条件 | OK to freeze avoid repeated freeze/thaw cycles desiccated (hygroscopic) protect from light |
| 运输 | ambient |
| 储存温度 | ?20℃ |
安全信息
| 储存分类代码 | 10 - Combustible liquids |
| WGK | WGK 2 |
| 闪点(F) | 188.6 °F - (refers to pure substance) |
| 闪点(C) | 87 ℃ - (refers to pure substance) |
Sigma-Aldrich
m.cnreagent.com
